Skip to main content

The ultrasound difference

EKOS is a minimally invasive system for dissolving thrombus. The ultrasonic core generates an acoustic field which greatly accelerates lytic dispersion by driving the drug deeper into the clot and unwinding the fibrin to expose plasminogen receptor sites.
Acoustic Pulse

 

 

EKOS' targeted ultrasound waves accelerate thrombus dissolution by unwinding the fibrin matrix.1

Ultrasound image of fibrin before treatment
Before EKOS ultrasound
Tightly wound fibrin prevents lytic from reaching receptor sites.
Utrasound image of fibrin with acoustic pulse
After EKOS ultrasound
Ultrasonic energy thins fibrinand exposes receptor sites.

EKOS™ Endovascular System

ProductWorking LengthTreatment Zone

500-55106

106 cm

6 cm

500-55118

106 cm

18 cm

500-55124

106 cm

24 cm

500-55130

106 cm

30 cm

500-55140

106 cm

40 cm

500-55150

106 cm

50 cm

5.4 F infusion catheter for all EKOS products.
106 cm infusion catheter (0.035" guidewire compatible) with one ultrasonic core matched to corresponding length.
ProductWorking LengthTreatment Zone

500-56112

135 cm

12 cm

500-56130

135 cm

30 cm

500-56140

135 cm

40 cm

500-56150

135 cm

50 cm

135 cm infusion catheter (0.035" guidewire compatible) with one ultrasonic core matched to corresponding length.


 

EKOS™+ Endovascular System

ProductWorking lengthTreatment zone
H74939605106080

106 cm

8 cm

H74939605106120

106 cm

12 cm

H74939605106160

106 cm

16 cm

H74939605106200

106 cm

20 cm

7.8 F infusion catheter for all EKOS+ products.
106 cm infusion catheter (0.035" guidewire compatible) with one ultrasonic core matched to corresponding length.
ProductWorking lengthTreatment zone

H74939605135080

135 cm

8 cm

H74939605135120

135 cm

12 cm

H74939605135160

135 cm

16 cm

H74939605135200

135 cm

20 cm

135 cm infusion catheter (0.035" guidewire compatible) with one ultrasonic core matched to corresponding length.

 

1. Braaten JV et al. Ultrasound reversibly disaggregates fibrin fibers.Thromb Haemost 1997;78:1063-8
Top